Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma

被引:1
作者
Fanaroff, Rachel E. [1 ,2 ]
Yang, Soo-Ryum [1 ]
Tan, Kay See [3 ]
Adusumilli, Prasad S. [4 ]
Bodd, Francis [1 ]
Bowman, Anita [1 ]
Chang, Jason [1 ]
Offin, Michael D. [5 ,6 ]
Reiner, Allison [3 ]
Rekhtman, Natasha [1 ]
Rusch, Valerie W. [4 ]
Travis, William D. [1 ]
Zauderer, Marjorie G. [5 ,6 ]
Ladanyi, Marc [1 ]
Sauter, Jennifer L. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY 10029 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY USA
[6] Weill Cornell Med Coll, Dept Med, New York, NY USA
基金
美国国家卫生研究院;
关键词
BAP1; CDKN2A; diffuse pleural mesothelioma; NF2; SETD2; TP53; MALIGNANT MESOTHELIOMA; HOMOZYGOUS DELETION; PROGNOSTIC-FACTORS; BAP1; MUTATIONS; IMMUNOHISTOCHEMISTRY; SURVIVAL; CDKN2A; COMBINATION; EXPRESSION;
D O I
10.1016/j.modpat.2025.100706
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Histologic features, including architectural patterns, cytologic features, and 2021 World Health Organization nuclear grade have been shown to have prognostic significance in epithelioid diffuse pleural mesothelioma (DPM). Biphasic and sarcomatoid DPM, regardless of morphology, have worse outcomes. These prognostic findings are well established but the correlation of architectural patterns, cytologic features, and nuclear grade with genetic alterations has not been well studied. To investigate relationships between histologic findings and genomic alterations, 128 treatment-na & iuml;ve DPM specimens (70% epithelioid, 23% biphasic, and 6.3% sarcomatoid) with next-generation sequencing data were retrospectively reviewed. Alterations in BAP1 were the most common genomic alteration (n = 62, 48%), followed by CDKN2A (n = 49, 38%) and NF2 (n = 38, 30%). NF2 alterations were significantly more frequent in biphasic DPM (53% in biphasic vs 25% in sarcomatoid and 22% in epithelioid DPM; P = .005). In epithelioid DPM, TP53 alterations were associated with the presence of prognostically unfavorable histology, including micropapillary or solid architecture, pleomorphic features, and high nuclear grade. Tumors with low tumor-infiltrating lymphocytes (TILs) had a higher rate of BAP1 alterations than tumors with higher levels of TILs (67% vs 30%; P = .002). The findings of this study enhance our understanding of the relationships among prognostically significant histologic and molecular features of DPM and provide preliminary data to support increased integration of these findings in clinical diagnosis of pleural mesothelioma. (c) 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 50 条
[1]   Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population [J].
Ahmadzada, Tamkin ;
Cooper, Wendy A. ;
Holmes, Mikaela ;
Mahar, Annabelle ;
Westman, Helen ;
Gill, Anthony J. ;
Nordman, Ina ;
Yip, Po Yee ;
Pal, Abhijit ;
Zielinski, Rob ;
Pavlakis, Nick ;
Nagrial, Adnan ;
Daneshvar, Dariush ;
Brungs, Daniel ;
Karikios, Deme ;
Aleksova, Vesna ;
Grau, Georges E. ;
Burn, Juliet ;
Asher, Rebecca ;
Hosseini-Beheshti, Elham ;
Reid, Glen ;
Clarke, Stephen ;
Kao, Steven ;
Asher, Rebecca .
JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (04) :1-15
[2]   Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas [J].
Berg, Kyra B. ;
Dacic, Sanja ;
Miller, Caitlyn ;
Cheung, Simon ;
Churg, Andrew .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (12) :1549-1553
[3]   Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma [J].
Bilecz, Agnes ;
Stockhammer, Paul ;
Theegarten, Dirk ;
Kern, Izidor ;
Jakopovic, Marko ;
Samarzija, Miroslav ;
Klikovits, Thomas ;
Hoda, Mir A. ;
Dome, Balazs ;
Oberndorfer, Felicitas ;
Muellauer, Leonhard ;
Fillinger, Janos ;
Kovacs, Ildiko ;
Pirker, Christine ;
Schuler, Martin ;
Ploenes, Till ;
Aigner, Clemens ;
Klepetko, Walter ;
Berger, Walter ;
Brcic, Luka ;
Laszlo, Viktoria ;
Hegedus, Balazs .
HISTOPATHOLOGY, 2020, 77 (01) :55-66
[4]   The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma [J].
Bott, Matthew ;
Brevet, Marie ;
Taylor, Barry S. ;
Shimizu, Shigeki ;
Ito, Tatsuo ;
Wang, Lu ;
Creaney, Jenette ;
Lake, Richard A. ;
Zakowski, Maureen F. ;
Reva, Boris ;
Sander, Chris ;
Delsite, Robert ;
Powell, Simon ;
Zhou, Qin ;
Shen, Ronglai ;
Olshen, Adam ;
Rusch, Valerie ;
Ladanyi, Marc .
NATURE GENETICS, 2011, 43 (07) :668-U81
[5]   Clinical significance of histologic subtyping of malignant pleural mesothelioma [J].
Brcic, Luka ;
Kern, Izidor .
TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) :924-933
[6]   Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations [J].
Bueno, Raphael ;
Stawiski, Eric W. ;
Goldstein, Leonard D. ;
Durinck, Steffen ;
De Rienzo, Assunta ;
Modrusan, Zora ;
Gnad, Florian ;
Nguyen, Thong T. ;
Jaiswal, Bijay S. ;
Chirieac, Lucian R. ;
Sciaranghella, Daniele ;
Dao, Nhien ;
Gustafson, Corinne E. ;
Munir, Kiara J. ;
Hackney, Jason A. ;
Chaudhuri, Amitabha ;
Gupta, Ravi ;
Guillory, Joseph ;
Toy, Karen ;
Ha, Connie ;
Chen, Ying-Jiun ;
Stinson, Jeremy ;
Chaudhuri, Subhra ;
Zhang, Na ;
Wu, Thomas D. ;
Sugarbaker, David J. ;
de Sauvage, Frederic J. ;
Richards, William G. ;
Seshagiri, Somasekar .
NATURE GENETICS, 2016, 48 (04) :407-+
[7]  
Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011
[8]   Accelerating Discovery of Functional Mutant Alleles in Cancer [J].
Chang, Matthew T. ;
Bhattarai, Tripti Shrestha ;
Schram, Alison M. ;
Bielski, Craig M. ;
Donoghue, Mark T. A. ;
Jonsson, Philip ;
Chakravarty, Debyani ;
Phillips, Sarah ;
Kandoth, Cyriac ;
Penson, Alexander ;
Gorelick, Alexander ;
Shamu, Tambudzai ;
Patel, Swati ;
Harris, Christopher ;
Gao, JianJiong ;
Sumer, Selcuk Onur ;
Kundra, Ritika ;
Razavi, Pedram ;
Li, Bob T. ;
Reales, Dalicia N. ;
Socci, Nicholas D. ;
Jayakumaran, Gowtham ;
Zehir, Ahmet ;
Benayed, Ryma ;
Arcila, Maria E. ;
Chandarlapaty, Sarat ;
Ladanyi, Marc ;
Schultz, Nikolaus ;
Baselga, Jose ;
Berger, Michael F. ;
Rosen, Neal ;
Solit, David B. ;
Hyman, David M. ;
Taylor, Barry S. .
CANCER DISCOVERY, 2018, 8 (02) :174-183
[9]   Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma [J].
Chapel, David B. ;
Hornick, Jason L. ;
Barlow, Julianne ;
Bueno, Raphael ;
Sholl, Lynette M. .
MODERN PATHOLOGY, 2022, 35 (10) :1383-1397
[10]   MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma [J].
Chapel, David B. ;
Schulte, Jefree J. ;
Berg, Kyra ;
Churg, Andrew ;
Dacic, Sanja ;
Fitzpatrick, Carrie ;
Galateau-Salle, Francoise ;
Hiroshima, Kenzo ;
Krausz, Thomas ;
Le Stang, Nolwenn ;
McGregor, Stephanie ;
Nabeshima, Kazuki ;
Husain, Aliya N. .
MODERN PATHOLOGY, 2020, 33 (02) :245-254